课题基金 / 基金详情

Coupled translation: a novel process for translation of two overlapping open reading frames in mRNA

Coupled translation: a novel process for translation of two overlapping open reading frames in mRNA
耦合翻译:mRNA 中两个重叠开放阅读框翻译的新过程
批准号:
BB/F007612/1
负责人:
Andrew Easton
金额:
$44.9万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Andrew Easton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Translation is the final stage of the most fundamental process in biology in which the genetic material of the organism is turned into proteins. During the process of translation; ribosomes (which are the cellular machines that build proteins) make the new protein by following a plan written in a molecule called mRNA. mRNA is a single stranded molecule made up from 4 different components (called nucleotides) which act like letters in our alphabet to make a code. Scientists have been studying the way the ribosome machine works in eukaryotes (higher organisms) for many years and thought that all proteins are made in the same way. Viruses are a group of microscopic organisms which infect and cause diseases in other organisms. During the infection process they must use the infected cells apparatus including ribosomes to make more new viruses. Viruses have been forced to develop new methods to survive and multiply faster before the infected cell can destroy it. These new methods include the manipulation of the cells ribosomes to do novel things which benefit the virus. Importantly, all new strategies used by the virus must be compatible with the workings of the cell to function. Interestingly, by studying these new strategies Scientists have seen that not only, do the viruses use them, but the cells also do. We are studying a virus called RSV which most individuals will have likely to have been infected with as a child and will have a good chance of being infected again in the future. The RSV virus also uses a novel mechanism to express a protein called M2-2. Here instead of just making one protein from a piece of mRNA two proteins are made. We are interested in working out how this is possible. We have shown that in order to make the second protein: M2-2 the first protein M2-1 must be made. This means the ribosomes must go in reverse as the coding sequence for the second protein overlaps with the coding sequence of the first. This was an important finding as ribosomes had not previously been shown to have this ability. Important regions within this piece of mRNA have been discovered that allow the second protein to be made. These regions appear to be present thought the coding sequence of M2-1 which is amazing because in molecular terms this is a large distance. If we change these regions by introducing mutations the amounts of the second protein made are reduced. One region which is important in this process has been shown to contain a lot of secondary structure. Secondary structure occurs where the nucleotides in different parts of the mRNA molecule can interact together, which can be thought of as like fitting two pieces of a jig-saw together. As more pieces are added the structure gets stronger. We will further characterise the important segments within M2-1 to investigate the role they have on M2-2 production. To do this we must first finish mapping the position of all of the important regions. In particular we focus on the region that contains a lot of secondary structure. Different types of mutations will be introduced in these regions to confirm there importance. We also hope to examine in more detail the components of the ribosome machine that make the second protein M2-2. Finally we hope that we can solve the structure (complete the jig-saw) of the mRNA molecule to provide a bigger picture on this unique mechanism of protein expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FLIP - Commercial development of antivirals for bovine respiratory syncytial virus
  • 批准号:
    BB/M006263/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $2.66万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Novel Inhibitors of Bovine Respiratory Syncytial Virus
  • 批准号:
    BB/M005534/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1.02万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Small molecule inhibitors for bovine respiratory syncytial virus
  • 批准号:
    BB/L024438/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $24.81万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Analysis of the mechanism for coupled translation in cellular and virus mRNAs
  • 批准号:
    BB/I022880/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.05万
  • 财政年份:
    2011
  • 负责人:
    Andrew Easton
  • 依托单位:
国内基金
海外基金
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
  • 批准号:
    82371607
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    李铮
  • 依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
  • 批准号:
    82371738
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郑英霞
  • 依托单位:
白质消融性白质脑病中胶质细胞选择性受累的机制研究
  • 批准号:
    30872793
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2008
  • 负责人:
    吴晔
  • 依托单位:
白质消融性白质脑病致病基因EIF2B5的突变功能研究
  • 批准号:
    30772355
  • 项目类别:
    面上项目
  • 资助金额:
    29.0万元
  • 批准年份:
    2007
  • 负责人:
    姜玉武
  • 依托单位: